Summit Therapeutics Share Discussion Threads

[waterloo01] 23/5/2019 13:12

Sort of O/T. Limited if any real benefit. Price $840k per year per patient.

[algernon2] 22/5/2019 18:48

Sorry: it should have been "loose lips sink ships" I was wrong.Mea Culpa.

[algernon2] 22/5/2019 11:53

All springs are coiled, that's why they are called springs. Do you mean its a compressed spring ready to expand or an extended spring with nowhere to go in particular. Remember "loose lips cost lives!" so careful what you say.

[kirk 6] 20/5/2019 15:42

Disappointing day considering all the positive vibes over the weekend! Coiled spring comes to mind here

[waterloo01] 19/5/2019 16:46

Certainly seems to be a concerted push to change the investment landscape, especially with new classes of drug and a focus on being better, not just equivalent to existing treatments.

The whole space would be transformed if changes are made. Something between O'Neill's idea of 'taxing' big pharma that don't run antibiotic programmes to the FDA's suggestion of changing the way antibiotics are paid funded and paid for.

[kirk 6] 19/5/2019 14:54

Jags post regarding the sky news is pretty impressive aswell reckon we are on to a massive winner here

[chrisatrdg] 19/5/2019 11:57

Great post Bermudashorts I will now post on the other post & from reading the article it is a great mention of Summit in the context of where the next fight against C-Diff is coming from.

[bermudashorts] 18/5/2019 18:58

Nice mention for Ridinilazole here:-

'But there is an answer. In fact, two. One is a drug called Fidaxomicin – very expensive and definitely not government subsidized. The other, the one in which researchers including Riley hold great hope, is a new drug Ridinilazole.

Ridinilazole is now in Phase-3 clinical trials and is expected to become available in about two years.'

[kirk 6] 18/5/2019 16:48

Great news mate let's hope we surge back Into 30s next week

[jag63] 18/5/2019 14:16

Summ had a good mention today on Sky News in an interview with Paul McNeive,
author of The Manhattan Project and Ireland's leading motivational speaker discussing the issues he has had with antibiotic resistance after losing his legs in a fire. He has been working with Dame Sally Davies and highlighted the fact that Summ is showing some very positive results. Should help to get our name out there as he is speaking at several venues on the urgent need to get new antibiotics.

[kirk 6] 17/5/2019 11:42

Well let's hope they finally deliver , risk reward at this level is pretty impressive. We had a UK target of £1.60 per share if I remember correctly

[lagosboy] 14/5/2019 21:06

Problem with this mob is that they promise so much but never actually deliver anything except a very fine standard of living for Glyn.

He did just the same to Antisoma shareholders.

I hope for a happy ending but I have my doubts.

[chrisatrdg] 14/5/2019 20:50

RNS Out this evening
Annual Report & Accounts Y/E 31st January 2019 (AGM 19th June)

[football] 13/5/2019 16:39

To what? Doom and gloom

[kirk 6] 13/5/2019 12:45

Looks like we need to change the title of This thread

[chrisatrdg] 10/5/2019 17:33

Date Presentation Title Webcast

8 May 2019 Slingshot Insights Management Call ListenTranscript




Project Goal: Understanding Summit's Leadership Role in Creating the Next Generation of Antibiotics: A Conversation with Management

Edit: I read the transcript & found it very interesting.

[kirk 6] 07/5/2019 21:27

Up again on Nasdaq

[waterloo01] 07/5/2019 19:26

It will react to news as and when, but the biggest of which would be a change in sentiment toward antibiotics. Otherwise cashed up and not over priced. IMO

[kirk 6] 07/5/2019 19:14

Got to be due an upDay here soon ffs

[kirk 6] 04/5/2019 16:59

We're excited to be working with @Slingshot_Invst again, this time on a management call with Glyn Edwards and David Roblin. Join us on Wednesday, May 8 at 11am EDT to hear how we're doing #antibiotics differently: https://lnkd.in/dhHazqM